OP370: BD V. Mueller Brawley Scleral Wound Retractor

Sign in to add this product to your favorites!
| Price: | $49.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 15 eaches |
| Status: | Non-sterile |
Additional Details
BRAWLEY Scleral Wound Retractor
OP370
- Light, delicate, non-magnetic. Nickel, Silver. Overall length 1-1/4" (3.2cm)
- Packaged Non-Sterile
AccessGUDID Info
- FDA Product Code: HNI
- FDA Product Code Name: Retractor, ophthalmic
- GMDN Term Code: 45182
- GMDN Term Name: Self-retaining surgical retractor, reusable
- GMDN Term Description: A hand-operated, self-retaining, one-piece surgical instrument intended to be used to separate/draw aside the margins of a wound/incision to allow access to tissues/organs during open surgery; it is not intended to retract the ribs and is not dedicated to ophthalmic surgery, but may otherwise be clinically dedicated. It is designed as a one-piece device (i.e., not a mounting ring, or table-fixed assembly) having two legs with distal hooked blades and a self-retaining mechanism to maintain the legs in an open position for retraction. This is a reusable device.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
IN-DATE